Market Trends EyePoint stock jumps 10% on Duravyu study results (EYPT:NASDAQ)By admin8996erT0allFebruary 5, 2025 1001slideShares of EyePoint Pharmaceuticals (NASDAQ:EYPT) rose 10% Wednesday after the company reported positive six-month results from a phase 2 study…
